Royal Marsden opens large private unit in central London
by Philip Housden
The Royal Marsden expands its private care presence in London tomorrow (Wednesday 28 April) by officially opening a new research-led diagnostic outpatient and treatment facility in Cavendish Square.
Its new facility between Oxford Street and Harley Street offers world-leading standards of cancer care to patients in a calm, modern and reassuring environment.
Housed within an Edwardian listed building, it is a dedicated and comprehensive cancer diagnostic and treatment centre and part of The Royal Marsden’s Private Care service provision.
The venue offers patients fast and direct access to the hospital’s world-leading diagnostic and research-active consultants specialising in a full range of cancer services.
It houses a diagnostic imaging suite offering MRI, CT, X-ray, ultrasound and mammography, plus other clinical specialties including genetics, plastic surgery and reconstruction and pain management.
Diagnostic service
A one-stop diagnostic service will be offered at the centre where patients can expect to have an appointment booked following their initial inquiry, direct access to diagnostic services, same day scans and test results.
The centre is also home to a minor procedure suite and a medical day unit with bespoke treatment bays.
These are promised to provide the highest level of patient-focused care for UK and overseas patients who are receiving some of the most advanced cancer treatments.
Cavendish Square will initially see both private care and NHS patients ensuring that all those with suspected cancer receive quick access to diagnostic tests.
Integrated partnership
It will also contribute to the financial sustainability of The Royal Marsden, ensuring all patients benefit as part of the unique, integrated partnership between the hospital’s NHS and Private Care services.
Prof Chris Nutting, clinical director
This model means revenue generated from Private Care is re-invested back into the NHS foundation trust, ensuring that all patients can be offered the highest standards of cancer treatment and care.
Prof Chris Nutting, consultant clinical oncologist and clinical director of The Royal Marsden Private Care at Cavendish Square, said: ‘The Royal Marsden sees and treats 60,000 NHS and private patients every year and Cavendish Square is an exciting new development that will allow our multidisciplinary teams to offer world- class standards of cancer care to even more patients, diagnosing cancers faster with a targeted and personalised approach.’
Shams Maladwala, managing director
Managing director Shams Maladwala said: ‘Improving patient access to better and more rapid diagnostics is a priority at The Royal Marsden, and Cavendish Square is part of a broader strategy to diagnose cancer faster and earlier.
‘Thanks to our integrated model, patients seeking the very best private cancer treatment can do so safe in the knowledge that it is backed by the strictest safety standards and governance usually only seen in the NHS.
‘Further investment in the trust’s NHS services from Private Care revenue provides the best of both worlds for both patients and clinicians, supporting The Royal Marsden in continuing to be worldwide leaders in the field of cancer diagnosis, treatment, care, research and education.’
Royal Marsden has by far the highest private patient revenues in the NHS, with growth of £11.3m and 9.3% to reach £132.6m in 2019-20 – 20% of the NHS total.